For immediate release | 1 November 2023 |
Haydale Graphene Industries plc
('Haydale', the 'Company', or the 'Group')
Total Voting Rights
Haydale (AIM: HAYD), the global advanced materials group, announces that in accordance with Disclosure Guidance and Transparency Rule 5.6.1 the Company's total issued share capital is 1,798,462,051 ordinary shares of 0.1 pence each ("Ordinary Shares") with each Ordinary Share carrying the right to one vote. This is also the total voting rights figure which may be used by shareholders as the denominator for the calculations by which they can determine whether they are required to notify their interests in, or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
For further information:
Haydale Graphene Industries plc |
|
Keith Broadbent, CEO | Tel: +44 (0) 1269 842 946 |
Patrick Carter, CFO | |
|
|
Cavendish Capital Markets Limited (Nominated Adviser & Broker) |
|
Julian Blunt/Edward Whiley, Corporate Finance |
Tel: +44 (0) 20 7220 0500 |
Notes to Editors
Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale can deliver improvements in electrical, thermal, and mechanical properties, as well as toughness through its state-of-the-art functionalisation. Haydale has granted patents for its technologies in Europe, USA, Australia, Japan, and China and operates from five sites in the UK, USA, and the Far East.
For more information please visit: www.haydale.com
LinkedIn: Haydale-ltd
Twitter: @haydalegraphene
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.